多病共存老年糖尿病患者过度治疗及其相关风险因素
该研究为多中心研究的二次分析,纳入564例≥70岁、多病共存且多重用药的2型糖尿病患者,过度治疗定义为HbA1c<7.5%且使用≥1种非二甲双胍降糖药。结果显示35%患者存在过度治疗,严重肾功能损害及非全科医生的门诊或急诊就诊与过度治疗相关。
要点
- 过度治疗定义为HbA1c<7.5%且使用≥1种非二甲双胍降糖药,发生率为35%。
- 严重肾功能损害与过度治疗相关(PR 1.36,1.21-1.53)。
- 非全科医生门诊或急诊就诊≥3次与过度治疗相关(PR 1.35,1.19-1.54)。
核心结论
- 在多病共存老年2型糖尿病患者中,超过三分之一存在过度治疗,提示该问题高发。
- 在严重肾功能损害及频繁非全科医生医疗接触的情况下,选择降糖药物时仔细权衡获益与风险可能改善患者照护。
研究设计与样本
- 多中心研究的二次分析,纳入欧洲四所大学医学中心(比利时、爱尔兰、荷兰、瑞士)的564例2型糖尿病患者。
- 患者年龄≥70岁,多病共存(≥3种慢性诊断)且多重用药(≥5种慢性药物)。
- 过度治疗定义为HbA1c<7.5%且使用≥1种非二甲双胍降糖药,依据Choosing Wisely建议。
- 采用年龄和性别校正的患病率比(PR)评估过度治疗的风险因素。
主要发现
- 564例患者中位年龄78岁,女性占39%,HbA1c均值±标准差为7.2±1.2%。
- 二甲双胍是最常处方的降糖药(患病率51%),199例(35%)患者存在过度治疗。
- 严重肾功能损害与过度治疗相关(PR 1.36,1.21-1.53)。
- 非全科医生(即专科医生)门诊或急诊就诊1-2次与过度治疗相关(PR 1.22,1.03-1.46),≥3次与过度治疗相关(PR 1.35,1.19-1.54),均相较于无就诊。
- 上述因素在多变量分析中仍与过度治疗相关。
关键数值与推荐
- 过度治疗定义:HbA1c<7.5%且使用≥1种非二甲双胍降糖药。
临床怎么用
- 在多病共存老年2型糖尿病患者中,应关注HbA1c<7.5%且使用非二甲双胍降糖药的情况以识别过度治疗。
- 对于合并严重肾功能损害或频繁非全科医生医疗接触的患者,选择降糖药物时需仔细权衡获益与风险。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In multimorbid older patients with type 2 diabetes mellitus (T2DM), the intensity of glucose-lowering medication (GLM) should be focused on attaining a suitable level of glycated hemoglobin (HbA1c ) while avoiding side effects. We aimed at identifying patients with overtreatment of T2DM as well as associated risk factors. METHODS: In a secondary analysis of a multicenter study of multimorbid older patients, we evaluated HbA1c levels among patients with T2DM. Patients were aged ≥70 years, with multimorbidity (≥3 chronic diagnoses) and polypharmacy (≥5 chronic medications), enrolled in four university medical centers across Europe (Belgium, Ireland, Netherlands, and Switzerland). We defined overtreatment as HbA1c < 7.5% with ≥1 GLM other than metformin, as suggested by Choosing Wisely and used prevalence ratios (PRs) to evaluate risk factors of overtreatment in age- and sex-adjusted analyses. RESULTS: Among the 564 patients with T2DM (median age 78 years, 39% women), mean ± standard deviation HbA1c was 7.2 ± 1.2%. Metformin (prevalence 51%) was the most frequently prescribed GLM and 199 (35%) patients were overtreated. The presence of severe renal impairment (PR 1.36, 1.21-1.53) and outpatient physician (other than general practitioner [GP], i.e. specialist) or emergency department visits (PR 1.22, 1.03-1.46 for 1-2 visits, and PR 1.35, 1.19-1.54 for ≥3 visits versus no visits) were associated with overtreatment. These factors remained associated with overtreatment in multivariable analyses. CONCLUSIONS: In this multicountry study of multimorbid older patients with T2DM, more than one third were overtreated, highlighting the high prevalence of this problem. Careful balancing of benefits and risks in the choice of GLM may improve patient care, especially in the context of comorbidities such as severe renal impairment, and frequent non-GP healthcare contacts.
引用
- Baretella O, Alwan H, Feller M, et al. Overtreatment and associated risk factors among multimorbid older patients with diabetes. J Am Geriatr Soc. 2023. PMID: 37286338. doi:10.1111/jgs.18465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。